Limb-Girdle Muscular Dystrophy Type 2H Associated with Mutation in TRIM32, a Putative E3-Ubiquitin–Ligase Gene
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index; 11 of the 44 sources its claims cite were checked for support.
Abstract
Limb-girdle muscular dystrophy type 2H (LGMD2H) is a mild autosomal recessive myopathy that was first described in the Manitoba Hutterite population. Previous studies in our laboratory mapped the causative gene for this disease to a 6.5-Mb region in chromosomal region 9q31-33, flanked by D9S302 and D9S1850. We have now used additional families and a panel of 26 microsatellite markers to construct haplotypes. Twelve recombination events that reduced the size of the candidate region to 560 kb were identified or inferred. This region is flanked by D9S1126 and D9S737 and contains at least four genes. Exons of these genes were sequenced in one affected individual, and four sequence variations were identified. The families included in our study and 100 control individuals were tested for these variations. On the basis of our results, the mutation in the tripartite-motif-containing gene (TRIM32) that replaces aspartate with asparagine at position 487 appears to be the causative mutation of LGMD2H. All affected individuals were found to be homozygous for D487N, and this mutation was not found in any of the controls. This mutation occurs in an NHL (named after the proteins NCL1, HT2A, and LIN-41) domain at a position that is highly conserved. NHL domains are known to be involved in protein-protein interactions. Although the function of TRIM32 is unknown, current knowledge of the domain structure of this protein suggests that it may be an E3-ubiquitin ligase. If proven, this represents a new pathogenic mechanism leading to muscular dystrophy.
Overview
CoChat Summary
## TL;DR
The paper fine-maps the autosomal recessive LGMD2H locus in Manitoba Hutterite families from a 6.5 Mb interval to 560 kb and identifies TRIM32 D487N as the most likely disease-causing mutation. The authors propose that TRIM32 may function as an E3 ubiquitin ligase, suggesting a novel ubiquitin-proteasome mechanism for muscular dystrophy.
## Key findings
- Haplotype analysis in six interrelated Hutterite families identified 12 recombination events that reduced the LGMD2H candidate region from 6.5 Mb to 560 kb, flanked by D9S1126 and D9S737.
- Sequencing of the genes in this interval found four sequence variations; the best candidate was TRIM32 c.1459G>A (p.D487N).
- The paper reports that all 35 affected individuals with LGMD2H were homozygous for V4(Asn)/D487N, and the mutation was not observed in 100 controls.
- The altered residue lies in the third NHL domain of TRIM32 and is one of the two most highly conserved positions in that domain; the authors also state that TRIM32 shows two transcript sizes, 3.3 and 2.5 kb, and is expressed in skeletal muscle.
## Methods
- Studied 35 clinically affected Hutterite patients and their immediate families; genotypes were obtained for 117 individuals across six interrelated families, with 100 controls used for comparison.
- Performed haplotype analysis using 22 additional microsatellite markers to refine the disease interval, then used SSCA, DNA sequencing, and PCR/restriction assays to screen candidate genes and sequence variants.
- Assessed TRIM32 expression with a 12-tissue northern blot and used RT-PCR on RNA from cultured skin fibroblasts to examine whether the PAPPA silent variant affected splicing.
## Limitations
- The paper explicitly notes that the information they possessed did not exclude the possibility that V3 may contribute additional effects to the phenotype.
- They also state that they cannot exclude the possibility that V3 affects an exonic splicing enhancer active only in muscle or mRNA secondary structure; this is a stated uncertainty.
- Evident from the text: the causal claim is based on genetic segregation, absence in controls, and domain conservation, but the paper does not provide functional proof that TRIM32 D487N alters ubiquitin-ligase activity.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 4 Not valid · 19 Not checked · 55 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“TRIM32 has, from N- to C-terminal ends, a RINGfinger domain, a B1 box, a coiled-coil domain, and six NHLdomains”
What the sources say
- Could not verifycites Apweiler et al. 2001 sourceExperimental — accuracy not yet measured
The Integration Methods section (p. 2) explains how InterPro describes domains in multidomain proteins, but it does not describe TRIM32. Searches for TRIM32, RING finger, B1 box, coiled-coil, and NHL domains found no passage establishing the claimed domains, their order, or the count of six. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The V3(T) allele was found to have a frequency of 2% in controls.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Three recombination events were identified in individuals C-06, C-07, and E-11, thereby reducing the candidate region from 6.5 Mb to an interval of 713 kb flanked by D9S241 and D9S931 (fig. 1).”
plainstates a causen = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All affected individuals were found to be homozygous for D487N, and this mutation was not found in any of the controls.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“SSCA of exons located between the flanking microsatellitemarkers D9S1126 and D9S737 revealed only one silent substitution (i.e., V3) in PAPPA.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
26 more claims
Create a free account to see all 86 claims and every source verdict.
- Probably not a substantial claim. 40
- It may state two separate claims as one. 25
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Subjects and Methods
“Table 1 Four Sequence Variations Found in Exons within the LGMD2H Candidate Region”
§ Mutation Screening
“V1, an 11-bp deletion in intron 2 of PAPPA, can be excluded as the disease-causing mutation, because it does not segregate with LGMD2H and is outside the candidate region as defined by an inferred ancestral recombination event (in individual E-23; fig. 2).”
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · cited 1×
“Parkin, the product of PARK2, is known to be a RINGfinger–containing E3-Ub ligase (Shimura et al. 2000).”
BackgroundThe tripartite motif family identifies cell compartments
Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Riganelli, D., Zanaria, E., Messali, S., Cainarca, S., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2140 · Cited by 1,366 · cited 3×
“It was originally discovered using a yeast two-hybrid assay with the human immunodeficiency virus type 1 Tat acting as bait (Fridell et al. 1995; Reymond et al. 2001).”
BackgroundMethodJoazeiro, C. A. P., & Weissman, A. M. (2000) · Cell · doi:10.1016/s0092-8674(00)00077-5 · Cited by 1,249 · cited 2×
“It has been shown that the RINGfinger domain of an E3 ligase mediates interaction with the E2-conjugating enzyme and is the source of the ligase activity (Joazeiro and Weissman 2000).”
BackgroundApweiler, R. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.37 · Cited by 1,079
Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S., & Selkoe, D. J. (2001) · Science · doi:10.1126/science.1060627 · Cited by 1,053
Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y., & Takahashi, R. (2001) · Cell · doi:10.1016/s0092-8674(01)00407-x · Cited by 1,050
Recommendations for a nomenclature system for human gene mutations
Antonarakis, S. E., & Nomenclature Working Group (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)11:1<1::aid-humu1>3.0.co;2-o · Cited by 943
Slack, F. J., Basson, M., Liu, Z., Ambros, V., Horvitz, H. R., & Ruvkun, G. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80245-2 · Cited by 751
Cited by
Muscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089
Hatakeyama, S. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3139 · Cited by 802
“Point mutations in the human TRIM32 gene have been reported in two genetic disorders: limb-girdle muscular dystrophy type 2H (LGMD2H”
BackgroundTRIM family proteins: retroviral restriction and antiviral defence
Nisole, S., Stoye, J. P., & Saïb, A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1248 · Cited by 761
TRIM/RBCC, a novel class of ‘single protein RING finger’ E3 ubiquitin ligases
Meroni, G., & Diez‐Roux, G. (2005) · BioEssays · doi:10.1002/bies.20304 · Cited by 730
“mutated in Limb-Girdle Muscular Dystrophy type 2H (LGMD2H).((68)) In other cases of TRIM/RBCC genes involved in human diseases, the physiological targets and the pathogenesis of the symptoms are unknown.”
BackgroundSignaling pathways controlling skeletal muscle mass
Egerman, M. A., & Glass, D. J. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.857291 · Cited by 555
“Loss of desmin is responsible for a particular form of limb girdle muscular dystrophy (Frosk et al., 2002).”
BackgroundAlazami, A. M., Patel, N., Shamseldin, H. E., Anazi, S., Al-Dosari, M. S., Alzahrani, F., Hijazi, H., Alshammari, M., Aldahmesh, M. A., Salih, M. A., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.015 · Cited by 465
“Similarly, TRIM4 is a member of a family of proteins that has been implicated in a number of neurological disorders (TRIM2 in Charcot-Marie-Tooth, TRIM32 in Limb-Girdle Muscular Dystrophy, and TRIM18 in Opitz-GBBB (a syndromic form of intellectual disability) (Balastik et al., 2008; Frosk et al., 2002; Quaderi et al.,…”
BackgroundDurbeej, M., & Campbell, K. P. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00309-x · Cited by 435
Chiang, A. P., Beck, J. S., Yen, H.-J., Tayeh, M. K., Scheetz, T. E., Swiderski, R. E., Nishimura, D. Y., Braun, T. A., Kim, K.-Y. A., Huang, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600158103 · Cited by 433
Schwamborn, J. C., Berezikov, E., & Knoblich, J. A. (2009) · Cell · doi:10.1016/j.cell.2008.12.024 · Cited by 414
“TRIM32 is mutated in patients carrying limb girdle muscular dystrophy type 2H (Frosk et al., 2002).”
Membrane Repair: Mechanisms and Pathophysiology
Cooper, S. T., & McNeil, P. L. (2015) · Physiological Reviews · doi:10.1152/physrev.00037.2014 · Cited by 386
“Mutations in TRIM32 cause an autosomal recessive muscular dystrophy (LGMD2H) (92), although the disease mechanism is unknown.”
Sardiello, M., Cairo, S., Fontanella, B., Ballabio, A., & Meroni, G. (2008) · BMC Evolutionary Biology · doi:10.1186/1471-2148-8-225 · Cited by 279
“TRIM32 is involved in both a form of muscular dystrophy and a form of Bardet-Biedl Syndrome (BBS11), and MURF-1 is implicated in muscular atrophy [17-19].”
BackgroundCellular and molecular mechanisms underlying muscular dystrophy
Rahimov, F., & Kunkel, L. M. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201212142 · Cited by 239
Genetic basis of limb-girdle muscular dystrophies: the 2014 update.
Nigro, V., & Savarese, M. (2014) · PubMed Central · Cited by 310
Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins
Kawai, T., & Akira, S. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100160 · Cited by 229
“A homozygous mutation (D487N) in one of the C-terminal NHL domains of TRIM32 is the cause of limb-girdle muscular dystrophy type 2H, a degenerative myopathy characterized by pelvic girdle, shoulder girdle and quadriceps muscle 520 weakness (Frosk et al, 2002; Saccone et al, 2008).”
BackgroundMuscular dystrophies: genes to pathogenesis
Dalkilic, I., & Kunkel, L. M. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00048-0 · Cited by 220
Kudryashova, E., Kudryashov, D., Kramerova, I., & Spencer, M. J. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.068 · Cited by 207
Cohen, S., Zhai, B., Gygi, S. P., & Goldberg, A. L. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201110067 · Cited by 205
“In humans, mutations at the third NHL repeat cause limb girdle muscular dystrophy 2H (Frosk et al., 2002), but the effects of these mutations on its function are unclear.”
BackgroundInfluentialLimb-Girdle Muscular Dystrophy in the United States
Moore, S. A., Shilling, C. J., Westra, S., Wall, C., Wicklund, M. P., Stolle, C., Brown, C. A., Michele, D. E., Piccolo, F., Winder, T. L., et al. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000235854.77716.6c · Cited by 181
Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies.
Sandri, M., Coletto, L., Grumati, P., & Bonaldo, P. (2013) · Journal of Cell Science · doi:10.1242/jcs.114041 · Cited by 179
“A deregulation of the ubiquitin-proteasome system has also been reported for other muscular dystrophies, including limb girdle muscular dystrophy (LGMD) type 2H, type 2A and type 2B (Frosk et al., 2002).”
BackgroundInfluentialWatanabe, M., & Hatakeyama, S. (2017) · Journal of Biochemistry · doi:10.1093/jb/mvw087 · Cited by 176
Lionel, A. C., Tammimies, K., Vaags, A. K., Rosenfeld, J. A., Ahn, J. W., Merico, D., Noor, A., Runke, C. K., Pillalamarri, V. K., Carter, M. T., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt669 · Cited by 163
Limb‐girdle muscular dystrophies – from genetics to molecular pathology
Laval, S. H., & Bushby, K. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00555.x · Cited by 171
Calpain 3, the “gatekeeper” of proper sarcomere assembly, turnover and maintenance
Beckmann, J. S., & Spencer, M. J. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.08.005 · Cited by 178
“This postulated link with the proteasome is compatible with the fact that the E3 ubiquitin ligase Trim32, when mutated can also give rise to a LGMD [23].”
BackgroundResultThe 10 autosomal recessive limb-girdle muscular dystrophies
Zatz, M., Paula, F., Starling, A., & Vainzof, M. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(03)00100-7 · Cited by 147
“[20] Frosk P, Weiler T, Nylen E, et al.”
BackgroundInfluentialTRIM32 is an E3 ubiquitin ligase for dysbindin
Locke, M., Tinsley, C. L., Benson, M. A., & Blake, D. J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp167 · Cited by 145
“Western and northern blot analyses of TRIM32 and dysbindin have shown that each protein is expressed at relatively low levels in skeletal muscle compared with other tissues such as the brain (9,20,31) (SupplementaryMaterial, Fig.”
BackgroundCambiaghi, V., Giuliani, V., Lombardi, S., Marinelli, C., Toffalorio, F., & Pelicci, P. G. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5398-7_6 · Cited by 148
Limb–girdle muscular dystrophy: Diagnostic evaluation, frequency and clues to pathogenesis
Lo, H. P., Cooper, S. T., Evesson, F. J., Seto, J. T., Chiotis, M., Tay, V. S., Compton, A. G., Cairns, A. G., Corbett, A., MacArthur, D. G., et al. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.08.009 · Cited by 153
Suspitsin, E. N., & Имянитов, Е. Н. (2016) · Molecular Syndromology · doi:10.1159/000445491 · Cited by 136
Kano, S., Miyajima, N., Fukuda, S., & Hatakeyama, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6231 · Cited by 138
“Point mutations of human TRIM32 have been reported in two autosomal recessive genetic disorders: limb-girdle muscular dystrophy type 2H, which is a myopathy with a primary or predominant involvement of the pelvic or shoulder girdle musculature ( 15 ), and Bardet-Biedl syndrome, which is characterized by obesity, pigme…”
BackgroundHorn, E. J. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh003 · Cited by 126
EFNS guideline on diagnosis and management of limb girdle muscular dystrophies
Norwood, F., Visser, M., Eymard, B., et al. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01979.x · Cited by 126
“LGMD2H (TRIM32) is a relatively mild form seen in some areas of Canada with onset in the second or third decade and slow progression; most patients were still ambulant into their 50s [12].”
BackgroundLimb–girdle muscular dystrophies
Guglieri, M., Straub, V. W., Bushby, K., & Lochmüller, H. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32830efdc2 · Cited by 137
Bögershausen, N., Shahrzad, N., Chong, J. X., von Kleist-Retzow, J., Stanga, D., Li, Y., Bernier, F. P., Loucks, C. M., Wirth, R., Puffenberger, E. G., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.05.028 · Cited by 134
Satellite cell senescence underlies myopathy in a mouse model of limb-girdle muscular dystrophy 2H
Kudryashova, E., Kramerova, I., & Spencer, M. J. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59581 · Cited by 119
“For example, all mutations that result in muscle phenotypes (limb-girdle muscular dystrophy 2H [LGMD2H] and sarcotubular myopathy [STM]) occur in the C-terminal NHL domain of TRIM32 (4–8).”
Deficiency of the E3 ubiquitin ligase TRIM32 in mice leads to a myopathy with a neurogenic component
Kudryashova, E., Wu, J., Havton, L. A., & Spencer, M. J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp036 · Cited by 117
“Affected individuals were found to carry a homozygous mutation (D487N) in one of the C-terminal NHL domains of TRIM32 [NHL repeats are conserved domains defined by amino acid sequence homologies among Ncl-1, HT2A and Lin-41 proteins (InterPro database)] (9).”
BackgroundResultCommonality of TRIM32 mutation in causing sarcotubular myopathy and LGMD2H
Schoser, B. G. H., Frosk, P., Engel, A. G., Klutzny, U., Lochmüller, H., & Wrogemann, K. (2005) · Annals of Neurology · doi:10.1002/ana.20441 · Cited by 112
“We speculate that the mutation abolishes this interaction; as a result, the still to be identified target protein(s) will not be ubiquinated, and hence not degraded by the proteasome machinery, and thus accumulate to greater concentrations in the cell.(6) How these observations relate to the pathology of LGMD2H/STM is…”
BackgroundMethodInfluentialSelf-citationExtensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes
Piluso, G., Politano, L., Aurino, S., Fanin, M., Ricci, E., Ventriglia, V. M., Belsito, A., Totaro, A., Saccone, V., Topaloglu, H., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.028738 · Cited by 118
“Additional patients were from Argentina (3), Croatia (6), Slovenia (5), Germany (6), Greece (1), and Turkey ( 20 ).”
BackgroundTRIM family proteins: emerging class of RING E3 ligases as regulator of NF‐κB pathway
Tomar, D., & Singh, R. K. (2014) · Biology of the Cell · doi:10.1111/boc.201400046 · Cited by 115
“Mutations in TRIM20, TRIM18, TRIM32, TRIM37 are associated with familial Mediterranean fever, X-linked Opitz G/BBB syndrome, Limb-girdle muscular dystrophy type 2H, Mulibrey nanism respectively (French, 1997; Quaderi et al., 1997; Avela et al., 2000; Frosk et al., 2002).”
BackgroundDiagnosis and management of the limb girdle muscular dystrophies
Bushby, K. M. D. (2009) · Practical Neurology · doi:10.1136/jnnp.2009.193938 · Cited by 121
“LGMD2H was identified in the Hutterite population of Canada and is caused by mutations in the E3 ubiquitin ligase TRIM32 gene.(54) 55 Age at onset is typically from the mid twenties although it may be earlier in some cases.”
BackgroundSaccone, V., Palmieri, M., Passamano, L., Piluso, G., Meroni, G., Politano, L., & Nigro, V. (2008) · Human Mutation · doi:10.1002/humu.20633 · Cited by 107
“Homozygous p.D487N mutation of the TRIM32 gene (MIM] 602290) causes LGMD2H in 41 patients from Hutterite families [Frosk et al., 2002].”
BackgroundInfluentialMicroRNAs in Neural Stem Cells and Neurogenesis
Kawahara, H., Imai, T., & Okano, H. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00030 · Cited by 115
myotilin Mutation Found in Second Pedigree with LGMD1A
Hauser, M. A., Conde, C. B., Kowaljow, V., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/344532 · Cited by 104
“Mutations in TRIM32, a putative E3-ubiquitin-ligase gene, have been identified as the cause of LGMD2H (Frosk et al. 2002).”
BackgroundTrim32 reduces PI3K–Akt–FoxO signaling in muscle atrophy by promoting plakoglobin–PI3K dissociation
Cohen, S., Lee, D., Zhai, B., Gygi, S. P., & Goldberg, A. L. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201304167 · Cited by 103
“Like MuRF1, Trim32 contains a tripartite motif (RING; B-box; coiled-coil), but also has six NHL repeats with putative protein-binding properties (Slack and Ruvkun, 1998; Frosk et al., 2002), and mutations in the third repeat cause limb girdle muscular dystrophy 2H (LGMD-2H).”
BackgroundWeihl, C. C., Miller, S., Hanson, P. I., & Pestronk, A. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm037 · Cited by 104
“It is interesting that the loss of Trim32, an E3 ligase important in the ubiquitination of skeletal muscle-specific substrates, causes sarcotubular swelling in patients with LGMD2H (25).”
BackgroundCalpain 3 cleaves filamin C and regulates its ability to interact with γ‐ and δ‐sarcoglycans
Guyon, J. R., Kudryashova, E., Potts, A., Dalkilic, I., Brosius, M. A., Thompson, T. G., Beckmann, J. S., Kunkel, L. M., & Spencer, M. J. (2003) · Muscle & Nerve · doi:10.1002/mus.10465 · Cited by 102
BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5δ
Xu, L., Yang, L., MOITRA, P. K., Hashimoto, K., Rallabhandi, P., Kaul, S. C., Meroni, G., Jensen, J. P., Weissman, A. M., & D’Arpa, P. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00187-3 · Cited by 113
Limb-girdle muscular dystrophies — international collaborations for translational research
Thompson, R., & Straub, V. W. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.35 · Cited by 100
Ozz-E3, A Muscle-Specific Ubiquitin Ligase, Regulates β-Catenin Degradation during Myogenesis
Nastasi, T., Bongiovanni, A., Campos, Y., Männ, L., Toy, J. N., Bostrom, J., Rottier, R. J., Hahn, C. N., Conaway, J. W., Harris, A., et al. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00020-6 · Cited by 93
Nicklas, S., Otto, A., Wu, X., Miller, P., Stelzer, S., Wen, Y., Kuang, S., Wrogemann, K., Patel, K., Ding, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030445 · Cited by 88
“All of the identified LGMD2H mutations are located in the Cterminal NHL domain [2], [3], [4].”
Self-citationLimb girdle muscular dystrophies: update on genetic diagnosis and therapeutic approaches
Nigro, V., Aurino, S., & Piluso, G. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32834aa38d · Cited by 100
Gushchina, L. V., Kwiatkowski, T. A., Bhattacharya, S., & Weisleder, N. L. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.020 · Cited by 88
“Mutations in TRIM32 have been linked to Limb Girdle Muscular Dystrophy Type 2H (Frosk et al., 2002) and the protein has been shown to regulate ubiquitination of actin in skeletal muscle (Kudryashova, Kudryashov, Kramerova, & Spencer, 2005).”
BackgroundUbiquitin Ligases at the Heart of Skeletal Muscle Atrophy Control
Peris-Moreno, D., Cussonneau, L., Combaret, L., Polge, C., & Taillandier, D. (2021) · Molecules · doi:10.3390/molecules26020407 · Cited by 95
“TRIM32 is a RING E3 Ub ligase whose mutation is responsible for the development of limb girdle dystrophy 2H (LGMD2H) [207].”
Albor, A., El-Hizawi, S., Horn, E. J., Laederich, M. B., Frosk, P., Wrogemann, K., & Kulesz-Martin, M. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601655200 · Cited by 97
Self-citationDel Prete, D., Rice, R. C., Rajadhyaksha, A. M., & D'Adamio, L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.733626 · Cited by 86
Asymptomatic carriers for homozygous novel mutations in the FKRP gene: the other end of the spectrum
Paula, F., Vieira, N. M., Starling, A., Yamamoto, L. U., Lima, B., Pavanello, R. C. M., Vainzof, M., Nigro, V., & Zatz, M. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201066 · Cited by 81
Frosk, P., Greenberg, C. R., Tennese, A. A. P., Lamont, R. E., Nylen, E. G., Hirst, C., Frappier, D., Roslin, N. M., Zaik, M., Bushby, K. M. D., et al. (2004) · Human Mutation · doi:10.1002/humu.20110 · Cited by 93
“1459G4A (D487N), in TRIM32 as the putative causative mutation, and all known Hutterite patients in families that showed linkage to chromosome region 9q32 were homozygous for this mutation [Frosk et al., 2002].”
InfluentialSelf-citationTRIM8 modulates p53 activity to dictate cell cycle arrest
Caratozzolo, M. F., Micale, L., Turturo, M. G., Cornacchia, S., Fusco, C., Marzano, F., Augello, B., D’Erchia, A. M., Guerrini, L., Pesole, G., et al. (2012) · Cell Cycle · doi:10.4161/cc.11.3.19008 · Cited by 76
The TRIM-NHL Protein LIN-41 Controls the Onset of Developmental Plasticity in Caenorhabditis elegans
Tocchini, C., Keusch, J. J., Miller, S. B., Finger, S., Gut, H., Stadler, M. B., & Ciosk, R. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004533 · Cited by 77
“Defects in TRIM-NHL proteins have also been associated with human pathologies, for example TRIM32 has been implicated in the Bardet–Biedl Syndrome and the Limb-Girdle Muscular Dystrophy [12,26,27].”
BackgroundEmerging RNA-binding roles in the TRIM family of ubiquitin ligases
Williams, F. P., Haubrich, K., Perez-Borrajero, C., & Hennig, J. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0158 · Cited by 74
TRIM32 ubiquitin E3 ligase, one enzyme for several pathologies: From muscular dystrophy to tumours
Lazzari, E., & Meroni, G. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.023 · Cited by 74
Update on the Genetics of Limb Girdle Muscular Dystrophy
Mitsuhashi, S., & Kang, P. B. (2012) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2012.09.008 · Cited by 75
The Congenital and Limb-Girdle Muscular Dystrophies: Sharpening the Focus, Blurring the Boundaries
Kirschner, J., & Bönnemann, C. G. (2004) · Archives of Neurology · doi:10.1001/archneur.61.2.189 · Cited by 68
Pumilio-2 Regulates Translation of Nav1.6 to Mediate Homeostasis of Membrane Excitability
Driscoll, H. E., Muraro, N. I., He, M., & Baines, R. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0921-13.2013 · Cited by 75
“1, respectively (El-Husseini et al., 2001; Reymond et al., 2001; Frosk et al., 2002; Sardiello et al., 2008).”
A Journey with LGMD: From Protein Abnormalities to Patient Impact
Georganopoulou, D. G., Moisiadis, V. G., Malik, F. A., Mohajer, A., Dashevsky, T. M., Wuu, S. T., & Hu, C.-K. (2021) · The Protein Journal · doi:10.1007/s10930-021-10006-9 · Cited by 76
Origin and Diversification of TRIM Ubiquitin Ligases
Marín, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050030 · Cited by 75
“It is known that mutations in several human TRIM genes cause genetic diseases such as mulibrey nanism (TRIM37 mutations; [28]), Opitz syndrome (mutations in TRIM18/MID1, where the slash separates two alternative names used for a particular gene or protein; [29]), muscular dystrophy limb-girdle Type 2H (TRIM32; [30]),…”
BackgroundRyu, Y. S., Lee, Y., Lee, K. W., Hwang, C. Y., Maeng, J., Kim, J., Seo, Y., You, K., Song, B., & Kwon, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.241893 · Cited by 74
Delaunay, A., Bromberg, K. D., Hayashi, Y. K., Massimiliano Mirabella, A., Burch, D., Kirkwood, B. J., Serra, C., Malicdan, M. C. V., Mizisin, A. P., Roberta Morosetti, A., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001609 · Cited by 72
“Mutations in TRIM32 RING finger E3 ligase have been associated with Limb-Girdle Muscular Dystrophy (LGMD) type 2H [13] and sarcotubular myopathy [14].”
BackgroundBushby, K., & Beckmann, J. S. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00183-9 · Cited by 62
Limb-girdle muscular dystrophies: Where next after six decades from the first proposal (Review)
Mahmood, O. A., & Jiang, X. M. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2048 · Cited by 70
“LGMD2H 9q31-q34 TRIM32 E3-ubiquitin ligase (25)”
BackgroundProtein defects in neuromuscular diseases
Vainzof, M., & Zatz, M. (2003) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2003000500001 · Cited by 62
Volodin, A., Kosti, I., Goldberg, A. L., & Cohen, S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612988114 · Cited by 66
“Proc Natl Acad Sci USA 95(19):11312–11317.”
BackgroundDinçer, P., Balcı-Hayta, B., Yuva, Y., Talim, B., Brockington, M., Dinçel, D., Torelli, S., Brown, S., Kale, G., Haliloğlu, G., et al. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(03)00161-5 · Cited by 65
TRIM44 interacts with and stabilizes terf, a TRIM ubiquitin E3 ligase
Urano, T., Usui, T., Takeda, S., Ikeda, K., Okada, A., Ishida, Y., Iwayanagi, T., Otomo, J., Ouchi, Y., & Inoue, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.010 · Cited by 64
Gene Expression Profiling in Limb-Girdle Muscular Dystrophy 2A
Sáenz, A., Azpitarte, M., Armañanzas, R., Leturcq, F., Alzualde, A., Inza, I., Garcia-Bragado, F., de la Herrán, G., Corcuera, J., Cabello, A., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003750 · Cited by 62
“It should also be noted that Trim32, found mutated in limb-girdle muscular dystrophy type 2H, is another putative E3-ubiquitin-ligase [50].”
BackgroundWilliams–Beuren syndrome TRIM50 encodes an E3 ubiquitin ligase
Micale, L., Fusco, C., Augello, B., Napolitano, L. M. R., Dermitzakis, E. T., Meroni, G., Merla, G., & Reymond, A. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.68 · Cited by 60
TRIM32 promotes neural differentiation through retinoic acid receptor-mediated transcription
Sato, T. Z., Okumura, F., Kano, S., Kondo, T., Ariga, T., & Hatakeyama, S. (2011) · Journal of Cell Science · doi:10.1242/jcs.088799 · Cited by 62
“Point mutations of the human TRIM32 gene have been reported in two genetic disorders: limb-girdle muscular dystrophy type 2H (LGMD2H) (Borg et al., 2009; Frosk et al., 2002), which is a myopathy with a predominant involvement of the pelvic or shoulder girdle musculature, and Bardet–Biedl syndrome (BBS), which is chara…”
BackgroundInfluentialA novel autosomal recessive limb-girdle muscular dystrophy with quadriceps atrophy maps to 11p13-p12
Jarry, J., Rioux, M., Bolduc, V., Robitaille, Y., Khoury, V., Thiffault, I., Tétreault, M., Loisel, L., Bouchard, J. P., & Brais, B. (2006) · Brain · doi:10.1093/brain/awl270 · Cited by 65
“Because TRIM32 is mutated in LGMD2H (Frosk et al., 2002), we decided to sequence TRIM44.”
BackgroundMethodMembrane Traffic in Skeletal Muscle
Towler, M. C., Kaufman, S. J., & Brodsky, F. M. (2004) · Traffic · doi:10.1111/j.1600-0854.2003.00164.x · Cited by 63
“Myotilin LGMD1A (93) Calpain-3 LGMD2A (94) Sarcoglycans a-SG LGMD2D Reviewed (6,9) b-SG LGMD2E g-SG LGMD2C d-SG LGMD2F e-SG Myoclonus Dystonia Telethonin LGMD2G (95) TRIM-32 LGMD2H (96) Fukutin-related protein LGMD2I (97) Titin LGMD2J (98) Laminin-2 a chain Muscular Dystrophy C1A Reviewed (6) Caveolin 3 LGMD1C, Rippli…”
A population-based study of autosomal-recessive disease-causing mutations in a founder population.
Chong, J. X., Ouwenga, R., Anderson, R. L., Waggoner, D. J., & Ober, C. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.08.007 · Cited by 55
Loss of heterozygosity of TRIM3 in malignant gliomas
Boulay, J., Stiefel, U., Taylor, E., Dolder, B., Merlo, A., & Hirth, F. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-71 · Cited by 58
“1, respectively [20-23].”
Ins and outs of therapy in limb girdle muscular dystrophies
Danièle, N., Richard, I., & Bartoli, M. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.02.005 · Cited by 64
The Notch signaling pathway in skeletal muscle health and disease
Vargas‐Franco, D., Kalra, R., Draper, I., Pacak, C. A., Asakura, A., & Kang, P. B. (2022) · Muscle & Nerve · doi:10.1002/mus.27684 · Cited by 51
“Biallelic pathogenic variants in TRIM32 are associated with limbgirdle muscular dystrophy type R8 (LGMDR8, formerly known as LGMD2H).(144) The protein product is a ubiquitin ligase that localizes F IGURE 6 Key domains of the JAG2 (Jagged2) protein are conserved across multiple species.”
BackgroundLimb-girdle muscular dystrophy 2H and the role of TRIM32
Shieh, P. B., Kudryashova, E., & Spencer, M. J. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-08-045031-5.00009-8 · Cited by 54
“TRIM32 protein is expressed widely in numerous tissues (Frosk et al., 2002; Horn et al., 2004), but is particularly well represented in the brain (Frosk et al., 2002; Horn et al., 2004; Kudryashova et al., 2005), where it was shown to be expressed at 100-fold the level in muscle (Kudryashova et…”
BackgroundInfluentialClinical genetics and the Hutterite population: a review of Mendelian disorders.
Boycott, K. M., Parboosingh, J. S., Chodirker, B. N., Lowry, R. B., McLeod, D. R., Morris, J., Greenberg, C. R., Chudley, A. E., Bernier, F. P., Midgley, J., et al. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32245 · Cited by 50
“…this strategy has been used tomap, and facilitate identification of, the genes for limb-girdle muscular dystrophy (LGMD2H) [Weiler et al., 1998; Frosk et al., 2002b], Usher syndrome (USH1F) [Wayne et al., 1997; Alagramam et al., 2001], dysequilibrium syndrome [Boycott et al., 2005], and…”
BackgroundMethodSelf-citationGuglieri, M., Magri, F., & Comi, G. P. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.05.020 · Cited by 52
“[121], suggests that it may be an E3-ubiquitin ligase implicated in the ubiquitin– proteosome pathway.”
BackgroundDegrons: defining the rules of protein degradation
Zhang, Z., Mena, E. L., Timms, R. T., Koren, I., & Elledge, S. J. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00870-z · Cited by 71
“Other E3 mutations linked to diseases include RFWD3 in Fanconi anaemia 202 , RNF213 in Moyamoya disease 203 , TRIM32 in limb–girdle muscular dystrophy 204,205 and MuRF1 in skeletal muscle atrophy 206 .”
Genes predict long distance migration and large body size in a migratory fish, Pacific lamprey
Hess, J. E., Caudill, C. C., Keefer, M. L., McIlraith, B. J., Moser, M. L., & Narum, S. R. (2014) · Evolutionary Applications · doi:10.1111/eva.12203 · Cited by 54
“…(DNAHC8, Samant et al. 2002; Etr_393), stabilization of dynamic microtubules (CLASP2, Maia et al. 2012; Etr_1257), muscle functioning (TRIM32, Frosk et al. 2002; Etr_3295), as well as relatively uncharacterized functions of a signaling protein (WAC, Xu and Arnaout 2002; Etr_320) and zinc…”
BackgroundDiMenna, E. L., Clark, K. A., Bauman, K., Parker, D. S., Cripps, R. M., & Geisbrecht, E. R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208408109 · Cited by 53
Winter, D. L., Paulin, D., Mericskay, M., & Li, Z. (2013) · Histochemistry and Cell Biology · doi:10.1007/s00418-013-1148-z · Cited by 58
“Mutations in TRIM32 are associated with myopathies, such as limbgirdle muscular dystrophy (Frosk et al. 2002; Kudryashova et al. 2011; Saccone et al. 2008; Shieh et al. 2011) and sarcotubular myopathy (Schoser et al. 2005).”
BackgroundKudryashova, E., Struyk, A., Mokhonova, E., Cannon, S. C., & Spencer, M. J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr311 · Cited by 46
“Aspartic acid at position 487 (human TRIM32) or 489 (mouse TRIM32) is one of the most highly conserved residues in these domains; the majority of the over 100 known NHL motifs have an aspartate, several have a glutamate and one has a lysine, at this position (4,10).”
BackgroundLimb-Girdle Muscular Dystrophy Overview
Pegoraro, E., & Hoffman, E. P. (2012) · Padua Research Archive (University of Padova) · Cited by 48
Limb-girdle muscular dystrophy
Mathews, K. D., & Moore, S. A. (2003) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-003-0042-9 · Cited by 46
The Childhood Limb-Girdle Muscular Dystrophies
Straub, V. W., & Bushby, K. M. D. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.06.006 · Cited by 45
Tripartite motif 32 prevents pathological cardiac hypertrophy
Chen, L., Huang, J., Ji, Y., Zhang, X., Wang, P., Deng, K., Jiang, X., Ma, G., & Li, H. (2016) · Clinical Science · doi:10.1042/cs20150619 · Cited by 46
An update on diagnostic options and considerations in limb-girdle dystrophies
Angelini, C. I., Giaretta, L., & Marozzo, R. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1508997 · Cited by 46
“Hutterite population in Canada) is present [5].”
Zhu, J.-W., Zou, M.-M., Li, Y.-F., Chen, W.-J., Liu, J.-C., Chen, H., Fang, L., Zhang, Y., Wang, Z.-T., Chen, J.-B., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz306 · Cited by 45
“The RING-finger domain displays E3 ligase activity, and the coiled-coil domain is involved in protein binding (Frosk et al. 2002).”
BackgroundInfluentialRole of calpains in promoting desmin filaments depolymerization and muscle atrophy
Cohen, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118788 · Cited by 48
Targeting TRIM Proteins: A Quest towards Drugging an Emerging Protein Class
D’Amico, F., Mukhopadhyay, R., Ovaa, H., & Mulder, M. P. C. (2021) · ChemBioChem · doi:10.1002/cbic.202000787 · Cited by 46
The E3 ubiquitin ligase TRIM32 regulates myoblast proliferation by controlling turnover of NDRG2
Mokhonova, E. I., Avliyakulov, N. K., Kramerova, I. A., Kudryashova, E., Haykinson, M. J., & Spencer, M. J. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv049 · Cited by 43
The limb-girdle muscular dystrophies—Diagnostic strategies
Bushby, K., Norwood, F., & Straub, V. W. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.09.009 · Cited by 42
Metadata
- Authors
- Frosk, P., Weiler, T., Nylen, E., Sudha, T., Greenberg, C. R., Morgan, K., Fujiwara, T. M., & Wrogemann, K.
- Affiliations
- University of Manitoba (CA)
- Research Institute of the McGill University Health Centre (CA)
- Corresponding author
- Wrogemann, Klaus
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 70
- Issue
- 3
- Pages
- 663-672
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC447621
- OpenAlex
- W2024140773
- Semantic Scholar
- 2761196aa5154b43901a405f8b3d734bf576cfe7
- Cited by
- 261
- References
- 34
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 8 · 2020: 13 · 2019: 12 · 2018: 5 · 2017: 7 · 2016: 9 · 2015: 9 · 2014: 18 · 2013: 16 · 2012: 17
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4158 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- TRIM32, E3 ubiquitin ligase, autosomal recessive myopathy, haplotype mapping, candidate gene mapping, protein-protein interaction
- MeSH terms
- Tripartite Motif Proteins, Amino Acid Sequence, Animals, DNA Mutational Analysis, Ethnicity, Exons, Female, Genetic Testing, Haplotypes, Homozygote, Humans, Ligases, Male, Manitoba, Molecular Sequence Data, Muscular Dystrophies, Mutation, Pedigree, RNA, Messenger, Transcription Factors, Consensus Sequence, Sequence Alignment, Protein Structure, Tertiary, Ubiquitin-Protein Ligases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.